ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,691,658 | +3.7% | 95,899 | -55.2% | 0.03% | +44.4% |
| Q3 2022 | $1,631,630 | +582.7% | 214,006 | +1243.2% | 0.02% | +500.0% |
| Q1 2021 | $239,000 | +2.6% | 15,932 | -33.0% | 0.00% | -25.0% |
| Q4 2019 | $233,000 | -60.8% | 23,787 | -43.1% | 0.00% | -81.0% |
| Q3 2018 | $595,000 | +17.6% | 41,770 | -1.0% | 0.02% | -32.3% |
| Q2 2018 | $506,000 | -33.6% | 42,184 | -31.6% | 0.03% | -45.6% |
| Q1 2018 | $762,000 | +429.2% | 61,672 | +511.2% | 0.06% | +375.0% |
| Q3 2017 | $144,000 | -71.9% | 10,091 | -75.0% | 0.01% | -75.0% |
| Q1 2017 | $513,000 | -28.3% | 40,419 | -42.2% | 0.05% | -22.6% |
| Q4 2016 | $715,000 | +280.3% | 69,987 | +391.5% | 0.06% | +210.0% |
| Q3 2016 | $188,000 | -21.7% | 14,239 | -24.6% | 0.02% | -35.5% |
| Q2 2016 | $240,000 | -63.6% | 18,874 | -56.0% | 0.03% | -75.4% |
| Q4 2015 | $660,000 | +230.0% | 42,915 | +166.2% | 0.13% | +142.3% |
| Q3 2015 | $200,000 | -22.5% | 16,121 | -14.7% | 0.05% | +15.6% |
| Q2 2015 | $258,000 | – | 18,889 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |